RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 7 analysts with an average price target of $297.55. This is a potential upside of $19.67 (7.08%) from yesterday's end of day stock price of $277.88.

ResMed's activity chart (see below) currently has 161 price targets and 127 ratings on display. The stock rating distribution of RMD is 46.15% HOLD and 53.85% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.75% with an average time for these price targets to be met of 172.24 days.

Highest price target for RMD is $330, Lowest price target is $248, average price target is $293.6.

Most recent stock forecast was given by LAURA SUTCLIFFE from CITI on 18-Sep-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 6 are a HOLD (46.15%), 7 are a BUY (53.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$330

$51.41 (18.45%)

$285

22 days ago
(18-Sep-2025)

6/7 (85.71%)

$56.71 (20.75%)

42

Buy

$330

$51.41 (18.45%)

$120

22 days ago
(18-Sep-2025)

5/6 (83.33%)

$56.71 (20.75%)

110

Buy

$270

$-8.59 (-3.08%)

$250

2 months 24 days ago
(16-Jul-2025)

12/12 (100%)

$15.75 (6.19%)

106

Hold

$248

$-30.59 (-10.98%)

$260

5 months 16 days ago
(24-Apr-2025)

3/3 (100%)

$11.9 (5.04%)

70

Buy

$290

$11.41 (4.10%)

$286

5 months 16 days ago
(24-Apr-2025)

18/18 (100%)

$53.9 (22.83%)

353

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 172.24 days on average for the stock forecasts to be realized with a an average price target met ratio 69.75

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan works at KEYBANK and has 9 price targets and 5 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Laura Sutcliffe with highest potential upside - $51.41

Which analyst is the currently most reserved on RMD (ResMed)?

Matthew Taylor with lowest potential downside - -$114.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?